Amundi Has $52.35 Million Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Amundi boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 12.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 736,637 shares of the company’s stock after buying an additional 79,056 shares during the quarter. Amundi’s holdings in Henry Schein were worth $52,345,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Versant Capital Management Inc raised its position in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after purchasing an additional 335 shares during the period. Venturi Wealth Management LLC grew its stake in Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after buying an additional 569 shares during the last quarter. Quent Capital LLC raised its holdings in Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after acquiring an additional 323 shares during the period. Smartleaf Asset Management LLC lifted its position in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares during the last quarter. Finally, City State Bank bought a new stake in Henry Schein during the fourth quarter valued at about $55,000. 96.62% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on HSIC shares. UBS Group dropped their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target on the stock. Barrington Research reissued an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Jefferies Financial Group boosted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Trading Down 4.1 %

Shares of HSIC stock opened at $69.94 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a fifty day moving average of $74.77 and a 200-day moving average of $72.64. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.49. The stock has a market cap of $8.68 billion, a price-to-earnings ratio of 28.78, a P/E/G ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the prior year, the business earned $0.66 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.